Literature DB >> 29722081

Liver alone or simultaneous liver-kidney transplant? Pretransplant chronic kidney disease and post-transplant outcome - a retrospective study.

Shunji Nagai1, Mohamed Safwan1, Kelly Collins1, Randolph E Schilke1, Michael Rizzari1, Dilip Moonka2, Kimberly Brown2, Anita Patel3, Atsushi Yoshida1, Marwan Abouljoud1.   

Abstract

The new Organ Procurement and Transplant Network/United Organ Sharing Network (OPTN/UNOS) simultaneous liver-kidney transplant (SLK) policy has been implemented. The aim of this study was to review liver transplant outcomes utilizing the new SLK policy. Liver transplant alone (LTA) and SLK patients between 2009 and 2015 were reviewed. Graft survival and post-transplant kidney function were investigated among LTA patients meeting the chronic kidney disease (CKD) criteria of the new policy (LTA-CKD group). To validate our findings, we reviewed and applied our analysis to the OPTN/UNOS registry. A total of 535 patients were eligible from our series. The LTA-CKD group (n = 27) showed worse 1-year graft survival, compared with the SLK group (n = 44), but not significant (81% vs. 93%, P = 0.15). The LTA-CKD group significantly increased a risk of post-transplant dialysis (odds ratio = 5.59 [95% CI = 1.27-24.7], P = 0.02 [Ref. normal kidney function]). Post-transplant dialysis was an independent risk factor for graft loss (hazard ratio = 7.25, 95% CI = 3.3-15.91, P < 0.001 [Ref. SLK]). In the validation analysis based on the OPTN/UNOS registry, the hazard of 1-year-graft loss in the LTA-CKD group (n = 751) was 34.8% higher than the SLK group (n = 2856) (hazard ratio = 1.348, 95% CI = 1.157-1.572, P < 0.001). Indicating SLK for patients who meet the CKD criteria may significantly improve transplant outcomes.
© 2018 Steunstichting ESOT.

Entities:  

Keywords:  Organ Procurement and Transplant Network; United Organ Sharing Network; chronic kidney disease; hepatorenal syndrome; liver-kidney transplantation

Year:  2018        PMID: 29722081     DOI: 10.1111/tri.13275

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

Review 1.  PRO: Simultaneous Liver-Kidney Transplantation in the Current Era: Still the Best Option.

Authors:  C Kristian Enestvedt
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

2.  The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and Outcomes.

Authors:  Mariya L Samoylova; Kara Wegermann; Brian I Shaw; Samuel J Kesseli; Sandra Au; Christine Park; Samantha E Halpern; Scott Sanoff; Andrew S Barbas; Yuval A Patel; Debra L Sudan; Carl Berg; Lisa M McElroy
Journal:  Liver Transpl       Date:  2021-07-14       Impact factor: 6.112

3.  Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net.

Authors:  Alejandro Pita; Navpreet Kaur; Juliet Emamaullee; Mary Lo; Brian Nguyen; Andrew Sabour; Vincent Tristan; Mitra Nadim; Yuri Genyk; Linda Sher
Journal:  Transplant Direct       Date:  2019-09-19

4.  Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States.

Authors:  Shingo Shimada; Toshihiro Kitajima; Yukiko Suzuki; Yasutaka Kuno; Tayseer Shamaa; Tommy Ivanics; Kelly Collins; Michael Rizzari; Atsushi Yoshida; Marwan Abouljoud; Dilip Moonka; Shunji Nagai
Journal:  Ann Transplant       Date:  2022-02-18       Impact factor: 1.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.